|Day's Range||46.28 - 46.87|
|52 Week Range||35.64 - 48.38|
|PE Ratio (TTM)||-2.84|
|Expense Ratio (net)||0.58%|
Biogen (BIIB) stock has risen ~0.40% in 2Q17 and ~4.1% year-to-date as of July 7, 2017.
Incyte reported revenues of $384.1 million in 1Q17 as compared to $263.5 million in 1Q16.
In 1Q17, Ionis Pharmaceuticals reported EPS (earnings per share) of $0.03 on revenue of $110.3 million, compared with EPS of -$0.52 on revenue of $36.9 million in 1Q16. In this series, we'll look at its ...